The Genuvi multiplex PCR panel provides a rapid, reliable, and clinically relevant diagnostic tool to guide treatment, limit viral spread, and improve outcomes in patients with respiratory symptoms. This panel is essential in both community and institutional settings to ensure timely and appropriate care.
Price
$85.00
USD
One of our agents will contact you
By clicking the “Subscribe” button, you agree to our Terms and Conditions and Privacy Policy.
The multiplex PCR panel for COVID-19, Influenza A/B, and RSV we offer provides rapid, accurate, and comprehensive molecular detection of the most prevalent respiratory viruses in a single test. This panel enhances diagnostic precision, supports effective isolation and treatment decisions, and helps reduce unnecessary antibiotic use.
This panel is recommended for:
- Patients with acute respiratory symptoms (e.g., cough, fever, shortness of breath)
- Hospitalized individuals with pneumonia or lower respiratory tract infection
- Pediatric and geriatric patients at high risk of respiratory complications
- Immunocompromised individuals
- Healthcare workers or caregivers with known or suspected exposures
- Situations requiring rapid differentiation between COVID-19, influenza, and RSV for targeted therapy and infection control
The panel simultaneously detects and differentiates the following respiratory viruses:
✅ Respiratory Syncytial Virus (RSV)
✅ Influenza A
✅ Influenza B
✅ COVID-19 (SARS-CoV-2)
This test helps to:
✅ Diagnose co-infections
✅ Guide treatment decisions (antivirals, isolation protocols)
✅ Reduce unnecessary antibiotic prescriptions
✅ Support public health monitoring and outbreak response
Panel type: Real-time reverse transcription multiplex PCR (RT-PCR)
Sample type: Nasopharyngeal swabs
Detected pathogens: SARS-CoV-2, Influenza A, Influenza B, RSV
Turnaround time: 24 hours from sample receipt
Shipping conditions: Cold chain (ice packs); ship within 24 hours
Regulatory status: Developed under validated laboratory protocols (CLIA ID: 10D2210020)
This multiplex respiratory panel uses real-time reverse transcription polymerase chain reaction (RT-PCR) to detect viral RNA. Patient samples are collected via nasopharyngeal, nasal, or oropharyngeal swabs, followed by RNA extraction and amplification using pathogen-specific primers and probes.
The assay is optimized to provide high sensitivity and specificity for clinical respiratory specimens. Each analysis includes internal and external controls, and results are interpreted by certified molecular professionals using validated analysis software.
The Genuvi multiplex PCR panel provides a rapid, reliable, and clinically relevant diagnostic tool to guide treatment, limit viral spread, and improve outcomes in patients with respiratory symptoms. This panel is essential in both community and institutional settings to ensure timely and appropriate care.